BRD4 and neuroblastoma: In neuroblastoma, the most common solid tumor of the neural crest cell origin in children, dBET57 was recently shown to target Brd4 ubiquitination, inhibit the super-enhancer-related genes ZMYND8 and TBX3, and exhibit a potent anticancer effect both in vitro and in vivo [120].